Haploidentical transplantation
Showing 1 - 25 of 7,489
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)
Recruiting
- Sickle Cell Disease
- Hematopoietic stem cell transplantation
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)
Completed
- Refractory Acute Myeloid Leukemia
- Sequential Packaging (SET)
- +4 more
-
Paris, FranceService d'hématologie Clinique Hôpital Saint Antoine
Jul 22, 2022
Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using
Recruiting
- Relapsed Pediatric ALL
- +2 more
- In Vitro T cells depletion using CliniMCAS system
-
Shanghai, ChinaShanghai Children's Medical Center
Sep 28, 2022
Blood Virome After Haploidentical Hematopoietic Stem Cell
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Geneva, SwitzerlandGeneva University Hospitals
Nov 21, 2022
Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)
Recruiting
- Hematological Malignancies
- Hematopoietic Stem Cell Transplantation
- PBSCs
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022
Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors
Not yet recruiting
- Haplo-identical Transplantation
- Transplantation
- Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
-
Paris, FranceService D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023
Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)
Recruiting
- Hematopoietic Organs; Disorder
- Total lymphoid irradiation
-
Hong Kong, Hong KongHong Kong Children's Hospital
Oct 4, 2023
Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)
Recruiting
- Hematopoietic Organs; Disorder
- CD62L depleted donor lymphocyte infusion
-
Hong Kong, Hong KongHong Kong Children's Hospital
Sep 6, 2023
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)
Recruiting
- Acute Lymphoblastic Leukemia
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023
Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,
Recruiting
- Acute Leukemia
- Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
- haploidentical hematopoietic stem cell transplantation
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 9, 2022
Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)
Recruiting
- Hematologic Malignancies
- Haplo HCT <55 years old
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 25, 2023
Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Suzhou (Individual ATG, ATG)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Acute Leukemia
- Individual ATG
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 12, 2022
Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)
Not yet recruiting
- Graft Vs Host Disease
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2023
Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))
Recruiting
- Hematologic Malignancy
- CD45RA depleted donor lymphocyte infusion (DLI)
-
Tuebingen,, Germany
- +1 more
Jul 13, 2023
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,
Recruiting
- Sickle Cell Disease
- haploidentical stem cell transplant
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 21, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022